N@N

IBB, UAMY, CLWT, SKHSY, BPAX, Added To Naked Short Lists Today

^{Published on 2012-01-27 06:20:12 - WOPRAI}
 

January 27, 2012 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , announced today that these select companies have been After the NASDAQ, AMEX, NYSE, OTCBB and Pinksheet naked short threshold lists. Ishares Nasdaq Biotechnology (NASDAQ:IBB), UNITED STATES ANTIMONY CORP (OTCBB:UAMY), EURO TECH HOLDINGS CO LTD (NASDAQ:CLWT), SEKISUI HOUSE-SPONS ADR (OTC:SKHSY), BIOSANTE PHARMACEUTICALS INC (NASDAQ:BPAX). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .

Ishares Nasdaq Biotechnology (NASDAQ:IBB) - ISHARE NQ BIOTCHThere is a failure to deliver in shares of IBB

UNITED STATES ANTIMONY CORP (OTCBB:UAMY) - United States Antimony Corporation engages in the production and sale of antimony and zeolite products in the United States. The company offers antimony oxide that is primarily used in conjunction with a halogen to form a synergistic flame retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper. Its antimony oxide is also used as a color fastener in paints, as a catalyst for the production of polyester resins for fibers and films, as a phosphorescent agent in fluorescent light bulbs, and as an opacifier for porcelains. The company also offers various grades of sodium antimonite, which is principally used as a fining agent for glass in cathode ray tubes used in television picture tubes, as well as a flame retardant; and antimony metal for use in bearings, storage batteries, and ordnance. In addition, it offers zeolite, which is used for various purposes, including soil amendment and fertilization, water filtration, sewage treatment, nuclear waste and other environmental cleanup, odor control, gas separation, and animal nutrition. The company was founded in 1968 and is based in Thompson Falls, Montana.There is a failure to deliver in shares of UAMY

EURO TECH HOLDINGS CO LTD (NASDAQ:CLWT) - Euro Tech Holdings Company Limited, through its subsidiaries and associated companies, engages in marketing and trading air, water, and waste water related process control, analytical, and testing instruments, as well as disinfection equipment and related automation systems. The company distributes a range of advanced air and water pollution control equipment, chlorination equipment, laboratory instruments, analyzers, test kits, and related supplies; and power generation related equipment, including recorders and power quality analyzers. It also manufactures air and water analytical instruments and testing equipment, as well as undertakes air, water, and waste-water treatment engineering projects. Euro Tech primarily sells its products through its retail shops and representative offices, as well as through independent sub-distributors to commercial customers, governmental agencies, or instrumentalities in Hong Kong and the Peoples Republic of China. The company was founded in 1971 and is headquartered in Hong Kong, Hong Kong.There is a failure to deliver in shares of CLWT

SEKISUI HOUSE-SPONS ADR (OTC:SKHSY) - Sekisui House, Ltd., together with its subsidiaries, engages in the construction, sale, purchase, and administration of residential properties in Japan. It undertakes civil engineering, carpenter, plastering, steeplejack, earthwork and concrete, stones, roofing, electrical, piping, tiles, bricks, blocks, steel structure, reinforcing, paving, sheet metal, glass, painting, waterproofing, interior finishing, installation of machinery and tools, heat insulating, telecommunication, furnishing, water facility, and fire fighting equipments works. The company also involves in the purchase, sale, exchange, lease, brokerage, agency, management, and appraisal of real estate; business related to regional development, urban development, and environmental improvement; land measurement and geological survey; the provision of construction materials and materials for tree-planting and gardening; the purchase and sale of furniture, interior decoration, household electric appliances, housing equipments, medical equipments, and daily sundry goods; and the collection, transportation, disposition, and recycle of waste. In addition, it engages in the management of privately operated home for elderly and other facilities with medical and nursing care; development, purchase, sale, and lease of computer software and information processing systems; purchase and sale of publications; and management of sporting and recreation facilities, training institutes, eating places, lodging accommodations, and stands. Further, the company engages in the planning, operation, and contracting of entertainments, and management of culture centers; the provision of trucking, warehousing, and security services; the loaning of moneys, guarantee of debts, and leasing of movable property; the holding, sale, purchase, and asset management of marketable securities; and business relating to advertising and non-life insurance agent. Sekisui House, Ltd. was founded in 1960 and is headquartered in Osaka, Japan.There is a failure to deliver in shares of SKHSY

BIOSANTE PHARMACEUTICALS INC (NASDAQ:BPAX) - BioSante Pharmaceuticals, Inc., a specialty pharmaceutical company, develops products for female sexual health and oncology. Its lead products include LibiGel (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD), which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) special protocol assessment; and Elestrin (estradiol gel) for the treatment of moderate-to-severe vasomotor symptoms associated with menopause, which is marketed in the U.S. by Azur Pharma, BioSantes licensee. The company is also developing a portfolio of cancer vaccines, three of which have been granted orphan drug designation, and are currently in various Phase II clinical trials. Its other products in development comprise Bio-T-Gel, a testosterone gel for male hypogonadism, or testosterone deficiency in men, which is licensed to Teva Pharmaceuticals; and The Pill-Plus that is a combination of estrogens, progestogens, and androgens for the treatment of female sexual dysfunction in women using oral or transdermal contraceptives, in Phase II clinical development using BioSante patented technology. In addition, the company is developing its calcium phosphate technology for aesthetic medicine, as well as seeking opportunities for its 2A/Furin and other technologies. BioSante Pharmaceuticals, Inc. was founded in 1996 and is based in Lincolnshire, Illinois.There is a failure to deliver in shares of BPAX

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About BUYINS.NET

WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.

BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,750,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.

All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.

BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.

BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.

You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.

Contact: Thomas Ronk / CEO www.BUYINS.net (800) 715-9999 tom@buyins.net